Tag
Tag: Gilead
Remdesivir Becomes the First Covid-19 Treatment Approved in Europe
Gilead Pays Billions for Access to Galapagos’ Pipeline
Belgian and US Biotechs Team up to Reduce CAR T Side Effects
Austrian Biopharma Reaches First HIV Vaccine Milestone
Galapagos Reports Promising Phase III Data in Rheumatoid Arthritis
More News! New Antibiotics, Biodegradable Bone Implants and Infectious Disease Action…
Novartis and Gilead’s CAR-T Therapies Now Compete for the Same Cancer Patients
This Small German Biotech is Dealing with Big Pharma in NASH and Autoimmune Disease
Galapagos and Gilead Launch the Fifth New Trial for Filgotinib this Year
BRIEF: Galapagos and Gilead add Lupus to their Growing List of Indications
